Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial

Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial

Gitte S Jensen,1 Miki Lenninger,1 Michael P Ero,2 Kathleen F Benson,1 1NIS Labs, Klamath Falls, OR, 2Machaon Diagnostics, Inc., Oakland, CA, USA Objective: The objective of this study is to evaluate the effects of consumption of nattokinase on hypertension in a North American hypertensive population...

Full description

Bibliographic Details
Main Authors: Jensen GS, Lenninger M, Ero MP, Benson KF
Format: Article
Language:English
Published: Dove Medical Press 2016-10-01
Series:Integrated Blood Pressure Control
Subjects:
Subtilisin NAT
systolic blood pressure
diastolic blood pressure
von Willebrand factor
plasma Renin activity.
Online Access:https://www.dovepress.com/consumption-of-nattokinase-is-associated-with-reduced-blood-pressure-a-peer-reviewed-article-IBPC

Internet

https://www.dovepress.com/consumption-of-nattokinase-is-associated-with-reduced-blood-pressure-a-peer-reviewed-article-IBPC

Similar Items